MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » KCI carves out TSS bedmaking biz to Getinge for $275M | Wall Street Beat

KCI carves out TSS bedmaking biz to Getinge for $275M | Wall Street Beat

By

MassDevice.com Wall Street Beat

Kinetic Concepts said it’s closed the sale of its Therapeutic Support Systems business to Swedish medical device company Getinge (PINK:GETI B) for $275 million.

The deal for the 1,300-worker KCI unit, which makes specialty therapeutic beds, calls for the San Antonio, Texas-based wound care giant to provide "certain transition services to Getinge for a period of time," according to a press release. The TSS business pulled in $247 million in sales last year, according to a separate release.

Getinge said the deal will augment its extended care business, better balancing equipment sales and recurring revenues. About 60% of TSS’s business comes from the U.S., the company said.

For its part, KCI said it plans to use the proceeds to "to reinvest in its core business and look for new growth opportunities."

"To the extent KCI has not reinvested proceeds from the TSS sale within 12 months, it will use any remaining funds to repay long-term debt obligations," according to the release.

 Insurers eye medical cost reductions
Health insurance companies will change their focus from expanding their market to controlling medical costs now that Obamacare is a sure thing, America’s Health Insurance Plans CEO Karen Ignagni tells Bloomberg.
Read more

 CareFusion still can’t make its annual report
CareFusion (NYSE:CFN), saying it’s still trying to figure out how the SEC wants it to account for leases of its Pyxis medicine dispensing devices, released preliminary results for its fiscal 1st quarter.

"While we are not able to provide a full financial update today, we now have a path toward completing the filing of our fiscal 2012 [annual report]. As our finance team completes this necessary work, the rest of our organization remains absolutely focused on our customers, as demonstrated in this quarter’s results," chairman & CEO Kieran Gallahue said in prepared remarks.

CareFusion reported preliminary sales of $593 million and operating expenses of $293 million for the 3 months ended Sept. 30, up 1.0% and down 4.9%, respectively.
Read more

 Alphatec closes Phygen buyout, drums up $9M
Alphatec (NSDQ:ATEC) closed its buyout of some of Phygen’s Autolok set screw locking technology for nearly 4.1 million shares of stock and $2 million in cash, plus another 1.2 million shares in an escrow account to be released in a year’s time.

Alphatec also drummed up $9.0 million in an equity financing round backed by a single, un-named investor, according to a regulatory filing.
Read more

 Sensimed raises $18M Series C round

Swiss ophthalmic device maker Sensimed AG closed an $18 million (17 million CHF) Series C round co-led by Wellington Partners, Agate Medical Investments and Vinci Capital/Renaissance PME and including existing backers the Sandoz Family Foundation, ELM Development and "successful entrepreneurs in the medical devices industry."
Read more

 Analysts’ ups and downs

  • Abiomed (NSDQ:ABMD): Raymond James starts coverage with "market perform" rating.
  • Align Technology (NSDQ:ALGN): Stifel Nicolaus initiates coverage with "buy" rating, $32 price target.
  • Allscripts (NSDQ:MDRX): Jefferies & Co. reiterates "hold" rating, raises price target from $10.50 to $13; Piper Jaffray downgrades from "neutral" to "underweight" rating, lowers price target from $12 to $7.
  • CareFusion (NYSE:CFN): Leerink Swann maintains “market perform” rating, $29 price target.
  • Covidien (NYSE:COV): Leerink Swann maintains "outperform" rating, ~$64 price target.
  • Dentsply International (NSDQ:XRAY): Stifel Nicolaus initiates coverage with "hold" rating.
  • HeartWare International (NSDQ:HTWR): Leerink Swann maintains "outperform" rating, lowers price target to $100 from $105.
  • Hospira (NYSE:HSP): Barclays maintains “equal weight” rating, lowers price target top $34 from $36; Leerink Swann maintains "market perform" rating, $33-34 price target.
  • Mako Surgical (NSDQ:MAKO): Canaccord Genuity reaffirms "hold" rating; Leerink Swann maintains "market perform" rating, $15 price target.
  • NxStage Medical (NSDQ:NXTM): Canaccord Genuity maintains "buy" rating, cuts price target to $17 from $22.50; Leerink Swann reiterates "outperform" rating, raises price target to $14-$16 from $16-$18.
  • Sirona Dental Systems (NSDQ:SIRO): Leerink Swann maintains "outperform" rating, ~$64 price target
  • St. Jude Medical (NYSE:STJ): Leerink Swann maintains “outperform” rating, $50 price target.
  • Syneron Medical Ltd. (NSDQ:ELOS): Leerink Swann maintains “outperform” rating, $16-$17 price target.
  • Unilife (NSDQ:UNIS): Leerink Swann maintains "outperform" rating, $5-$6 price target.

In case you missed it

RSS From Medical Design & Outsourcing

  • Forecasting the future of urology with Boston Scientific’s Meghan Scanlon
    Meghan Scanlon, Boston Scientific’s president of urology and pelvic health, discusses the field and the challenges and opportunities ahead. The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field, said Meghan Scanlon, SVP and president of urology and pelvic health at Boston Scientific (NYSE:BSX) That… […]
  • Women researchers receive a fraction of funding from the world’s biggest medtech companies
    The gender divide in medtech extends beyond leadership and into funding for investigational studies by U.S. physicians. Only 6.7% of physicians who received research payments from the world’s largest medical device companies in 2020 were women, according to an analysis of Medical Design & Outsourcing’s Big 100 list of medtech companies and CMS Open Payments… […]
  • Pentax Medical expands Vizient contract to include pediatric endoscopes
    Pentax Medical today announced it has expanded its contract with Vizient to include pediatric endoscopes. The contract will give Pentax Medical the ability to offer endoscopes to Vizient member hospitals through the Vizient Pediatric Program. The agreement also includes other value-added offerings, education opportunities and best practices. Get the full story on our sister site,… […]
  • Hologic plans to buy Bolder Surgical for $160M
    Hologic Inc. (NSDQ:HOLX) has a $160 million deal to acquire Bolder Surgical, a developer and manufacturer of advanced energy vessel sealing surgical devices. It’s the latest deal by Hologic, which has been spending COVID-19 test revenue generated by its diagnostics business on acquisitions across the company’s business lines, as CFO Karleen Oberton and CEO Steve MacMillan… […]
  • Koya Medical reports positive early results in Dayspring lymphedema trial
    Koya Medical this week announced positive results from a small, ongoing trial comparing its Dayspring compression treatment for lymphedema to a traditional pneumatic compression pump. The Oakland, California-based company secured FDA 510(k) clearance for the device last month, saying it was the first such approval for an active compression treatment enabling movement and mobility with… […]
  • OneProjects raises $17M to advance 4D cardiac imaging
    Irish-German cardiac imaging startup OneProjects today announced $8 million in Series A2 funding and two grants totaling $9 million. The company will use the new funds to complete product development, conduct clinical trials, gain FDA clearance and prepare for U.S. commercialization of the first product developed from its proprietary 4D cardiac imaging platform, Verafeye. The… […]
  • Women in Medtech 2021: Lindsay Fleming, Avient Corp. Commercial Manager, Healthcare — Color & Additives
    Lindsay Fleming is the Healthcare Commercial Manager for the Color & Additives division at Avient Corporation, a premier provider of specialty polymer formulations, color and additive systems, packaging solutions, and polymer distribution. She has been with the company for over 7 years and oversees the commercial growth development of the healthcare segment. She focuses on… […]
  • Women in Medtech 2021: Sarah Ehrlich, Argon Medical Devices Sustaining Mechanical Engineer
    Sarah Ehrlich, sustaining mechanical engineer at Argon Medical Devices, holds a B.S in mechanical engineering from the University of Texas at Tyler. “My parents knew I would become an engineer before I did,” she said. “Growing up, I was the big sister who put back together whatever my younger siblings decided to tear apart. I… […]
  • Four questions with AdvaMed’s Jen Brearey
    Jen Brearey is AdvaMed’s chief financial officer and chief operating officer, as well as executive director for the association’s inclusion diversity programs, which includes the industry initiative AdvaMed Advance and AdvaMed’s Women’s Executive Network. Ahead of our annual Women in Medtech edition of Medical Design & Outsourcing, we asked Brearey to share her expertise on gender… […]
  • Life Spine wins FDA clearance for ProLift micro expandable spacer
    Life Spine announced that it received FDA clearance to market its ProLift micro expandable spacer system for supporting micro-invasive procedures. Huntley, Illinois-based Life Spine designed its ProLift micro to support procedures ranging from endoscopic TLIFs to MIS TLIFs/PLIFs. The platform includes an 8mm width, self-locking expansion at any height (between 8mm and 16mm) to suit… […]
  • Achieve More with Medical Device Training and Certifications
    Any medical professional that deals with complex devices on a regular basis can benefit greatly from a wide range of medical device courses offered by The Center for Professional Innovation and Education (CfPIE). Each course offered is designed to advance your career under the instruction of trained, experienced, and actively practicing professionals in the field.… […]

Leave a Reply